Cancer Research UK

Read about research news, funding opportunities and events

If you are unable to view this message correctly, click here

 
Cancer Research UK
Your May 2022 Research Update
 

Dear Voornaam,

Welcome to your weekly Cancer Research UK Research Update email.  

Most people are aware of the positive impact Cancer Research UK and our research community has had on the cancer problem. What is less well known is our role and impact on the wider economy and life science sector specifically.

Last financial year, £1.8bn was invested in cancer research in the UK through public and private funds – for our part, Cancer Research UK invested £421m of this – about 20%. Our contribution rises to 50% if we only include public investment. Our primary interest at Cancer Research UK is, of course, patient impact – however the other aspect to this is the economic benefits these investments can bring to UK plc.

We recently commissioned an external consultancy to help make the economic case for investing in cancer research. They looked at the economic and societal impact in terms of job creation and economic output, you can see the full report here. When taken altogether, incredibly, every £1 invested in cancer research generated £2.80 of economic benefits.

So what? You might reasonably ask. As researchers and scientists our focus has to be on patient impact. However, demonstrating the wider economic benefits provides further justification for greater levels of government investment in cancer research and life science in general. The stronger our sector, the more success we can have in translating science, securing private investment and accelerating benefits for patients.

Also this week, we’re delighted to announce the shortlist for the Excellence in Cancer Research Nursing category of the Royal College of Nursing’s 2022 Nursing Awards. Congratulations to the finalists, the winner will be announced in October.

Iain Foulkes

Executive Director Research & Innovation

CEO Cancer Research Horizons

Cancer Research UK

 

FUNDING AND RESEARCH OPPORTUNITIES


 
10
Jul
 

KQ LABS ACCELERATOR PROGRAMME

10 July 2022


 
12
Jul
 

MULTIDISCIPLINARY PROJECT AWARD

12 July 2022


 
19
Jul
 

CANCER IMMUNOLOGY PROJECT AWARD

19 July 2022


 
21
Jul
 

BIOMARKER PROJECT AWARD

21 July 2022


 
21
Jul
 

PROSPECTIVE SAMPLE COLLECTION AWARD

21 July 2022


Therapeutic Catalyst

THERAPEUTIC CATALYST

 

Applications accepted all-year round


Francis Crick fellowship

THE FRANCIS CRICK INSTITUTE CLINICAL FELLOWSHIPS

 

Applications accepted all-year round


 
 
economic impact report image link
 

NEW REPORT SHOWS CANCER RESEARCH IS GOOD FOR THE ECONOMY

The report, Economic Impact of Cancer Research Investment, examined the value of cancer research and development to the UK economy. It found that, for every £1 spent on Cancer Research UK-funded research in the UK, £2.80 of benefit was generated for the UK economy.

Read the report
economic value image link
 

"WE KNOW THAT CANCER RESEARCH SAVES AND IMPROVES LIVES. WHAT IS LESS WELL KNOWN IS THE ROLE OF CANCER RESEARCH IN IMPROVING ECONOMIC GROWTH"

The economic value of cancer research to the UK is incredibly high. Why is it important that we know this, and what could it mean for the future of investment in cancer research…

Find out here
 
Brain conf image link

TWO WEEKS LEFT TO SECURE DISCOUNTED ENTRY TO THE BRAIN TUMOUR CONFERENCE

Register for our Brain Tumour Conference before 15 July and you'll save £100.

Join us in London on 5–7 September for the latest thinking on the developmental origins of brain tumours, understanding the tumour microenvironment and new therapeutic opportunities, and tools to manipulate the nervous system.  

There’ll also be plenty of opportunity to meet with international scientists working in brain tumour research – latest confirmed speakers include Paul Mischel (Stanford University School of Medicine), Harry Bulstrode (Francis Crick Institute) and Polina Anikeeva (MIT).

Secure your place now with early bird discount
 
PPI statement image link

OUR NEW STATEMENT OF INTENT FOR PPI

We're committed to involving people affected by cancer and the wider public in our work.  

We’ve published a new statement of intent for patient and public involvement (PPI), which outlines how we’re holding ourselves to account for PPI across our research funding activities.

 
Read our statement
 
RCN shortlist image link
 

SHORTLIST ANNOUNCED FOR 2022 ROYAL COLLEGE OF NURSING AWARD

Congratulations to the finalists in the Excellence in Cancer Research Nursing category: CRUK Senior Research Nurses Jo Hargroves (University College London Hospital) and Vivienne Wilson (Edinburgh Cancer Centre); Margot Creighton (Belfast Health and Social Care Trust); the Oncology Research Delivery Team at the Royal Free London NHS Foundation Trust; and the Hope Cancer Trials Centre research nurse team at University Hospitals of Leicester NHS Trust. 

The winner will be announced in October.

Find out more about the finalists
genomics podcast image link
 

DO WE FOCUS TOO MUCH ON GENOMICS?

In our podcast with Professor Sara Zanivan we talk about how understanding the tumour microenvironment has developed over the past 20 years, how the techniques of proteomics have really freed researchers to ask the important questions and why we could even see mass-spec proteomics in the clinic.

Also – she poses a really interesting question about the balance between proteomics and genomics… are we overly focussed on the genome?

Also, keep your ears open for our next episode featuring Professor Sir Leszek Borysiewicz – coming soon!

Listen here
 
3RS image link

FOUR NEW AWARDS SUPPORTING 3Rs

The Skills and Knowledge Transfer scheme is an annual competition with awards of up to £75k available for up to 2 years. The grants promote the exchange and uptake of 3Rs technologies that have already demonstrated a 3Rs impact.

Through their collaboration with Cancer Research UK, the National Centre for the Replacement, Refinement and Reduction of Animals in Research want to support cancer researchers transferring 3Rs approaches.

 
Learn more about the grants
 

UPCOMING RESEARCH EVENTS


 
05
Jul
 

WHAT MAKES A GOOD ANTIBODY TARGET?

 

Technical webinar from the Cancer Research Horizons AstraZeneca Antibody Alliance Laboratory

Online

1:30 PM 05 July 2022


 

05

Sep

 
 

07

Sep

 

CANCER RESEARCH UK BRAIN TUMOUR CONFERENCE

 

London, UK

05 September 2022


 

10

Oct

 
 

11

Oct

 

BLACK IN CANCER CONFERENCE

 

Empowering the next generation

London, UK

10 October 2022


 

14

Oct

 
 

16

Oct

 

MOLECULAR ANALYSIS FOR PRECISION ONCOLOGY CONGRESS

 

Amsterdam, Netherlands

14 October 2022


 

18

Oct

 
 

20

Oct

 

THE EARLY DETECTION OF CANCER CONFERENCE

 

Portland, Oregon, USA

18 October 2022


 

15

Nov

 
 

17

Nov

 

CANCER RESEARCH UK LUNG CANCER CONFERENCE

 

Manchester, UK

15 November 2022


 
 
 
 

WHAT DID YOU THINK OF THIS EMAIL?

We're always looking for ways to improve. Please give us your feedback by clicking on one of the below images and leaving a comment.

 
THUMBS UP
 
THUMBS DOWN